Market Cap (In INR)
1.44 Billion
Revenue (In INR)
1.04 Billion
Net Income (In INR)
-217.3 Million
Avg. Volume
174.81 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.0-41.2
- PE
- -
- EPS
- -
- Beta Value
- 0.52
- ISIN
- INE670X01014
- CUSIP
- Y5S74C106
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Omkar Pravin Herlekar
- Employee Count
- -
- Website
- https://lasalabs.com
- Ipo Date
- 2017-09-21
- Details
- Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
More Stocks
-
WHEN
-
SYENSSyensqo SA/NV
SYENS
-
BFHJ
-
ARG
-
HBCYFHSBC Holdings plc
HBCYF
-
HABAHamborner REIT AG
HABA
-
ADSL
-
BSENFBaselode Energy Corp.
BSENF